Latest Blogs
FDA Grants Orphan Drug Status to Telitacicept for Myasthenia Gravis
RemeGen, a pioneering Chinese biopharmaceutical company, is drawing global attention with the advancement of its novel drug, Telitacicept, in the treatment of generalized myasthenia gravis (gMG). As FDA grants orphan…
Innovations in Smart Pharma Packaging: Enhancing Patient Engagement
The pharmaceutical industry is rapidly embracing a transformative era marked by Innovations in Smart Pharma Packaging: Enhancing Patient Engagement. At the PPL Conclave 2025, held on March 7 in Hyderabad,…
The New Pillar of Indian Pharma: Free Trade Warehousing Zones
The COVID-19 pandemic disrupted global supply chains, exposing vulnerabilities in pharmaceutical logistics and highlighting the need for greater efficiency, agility, and resilience. One transformative solution that has emerged as the…
OneSource Specialty Pharma’s Bengaluru Unit 2 Achieves ANVISA GMP Certification
OneSource Specialty Pharma’s Bengaluru Unit 2 achieves ANVISA GMP Certification, a major milestone that affirms the company’s adherence to world-class pharmaceutical manufacturing standards. This significant achievement, granted by ANVISA (Agência…
Say Goodbye to Migraines with Vasograin EC: Cadila’s Latest Innovation
Cadila Pharmaceuticals has recently introduced Vasograin EC, an advanced formulation designed to provide effective relief from migraines. This new product features a US FDA-approved composition, underscoring the company’s dedication to…
Benefits and Challenges of Fixed-Dose Combination Drugs
In the rapidly evolving landscape of healthcare, Fixed-Dose Combinations (FDCs) are emerging as a key strategy to address complex therapeutic needs. These combinations involve the formulation of two or more…
Understanding the Differences Between Process and Product Validation in Pharma
In the highly regulated pharmaceutical industry, product consistency, safety, and efficacy are essential pillars of quality assurance. One of the most critical aspects of ensuring this is validation—specifically, Process Validation…
Sai Life Sciences Invests $150M in Cutting-Edge R&T Centre
Sai Life Sciences, one of India’s fastest-growing Contract Research, Development & Manufacturing Organizations (CRDMOs), has made a monumental stride in its mission to transform global pharmaceutical research. Sai Life Sciences…
Jynneos Vaccine Approved for Mpox Prevention in HIV Patients
Jynneos Vaccine Approved for Mpox Prevention in HIV Patients – this statement marks a significant turning point in the battle against Mpox, especially for immunocompromised populations. As the world continues…
Strides Pharma Excels in S&P Global’s Corporate Sustainability Assessment
Strides Pharma Science Limited, a global pharmaceutical company headquartered in Bengaluru, India, has achieved a significant milestone by securing an Environmental, Social, and Governance (ESG) score of 76 out of…
Glenmark Introduces Vancomycin Hydrochloride Injection in the US Market
Glenmark Pharmaceuticals Inc., USA, a subsidiary of Glenmark Pharmaceuticals Ltd., has recently launched Vancomycin Hydrochloride for Injection USP in the United States. Glenmark Introduces Vancomycin Hydrochloride Injection in the US…
LuNGS Alliance Offers Free Genetic Testing for Lung Cancer Patients Across India
The LuNGS (Lung Cancer Genomic Solutions) Alliance has initiated a groundbreaking program offering free Next-Generation Sequencing (NGS) biomarker testing for lung cancer patients across India. LuNGS Alliance Offers Free Genetic…
Green Energy in Pharma – Akums’ 600 kWp Solar Power Plant
Akums Drugs & Pharmaceuticals, a leading contract manufacturing pharmaceutical company in India, has taken a significant step towards sustainability by installing a 600 kWp rooftop solar power plant at its…
Life Science Innovation – DKSH’s Latest Move in Taiwan
DKSH Technology, a prominent Market Expansion Services provider, has recently announced its agreement to acquire Taqkey Science and Quantum Biotech, two esteemed life science reagent and consumables distribution companies based…
How Female Leaders Enhance Workplace Culture and Performance?
In the contemporary corporate landscape, prioritizing women’s inclusion in management roles is not merely a matter of equity but a strategic imperative that drives organizational success. How Female Leaders Enhance…
Effective Strategies to Combat Spring Allergies
Spring is a season of renewal and beauty, but for many, it also heralds the onset of seasonal allergies, commonly known as hay fever. Effective Strategies to Combat Spring Allergies…
How Hyderabad’s Genome Valley is Shaping the Future of Life Sciences sentence
Hyderabad, often dubbed the “City of Pearls,” has emerged as a pivotal hub for India’s life sciences industry. Central to this evolution is the development of integrated research campuses, which…
Revolutionizing Drug Safety: Tech Mahindra and NVIDIA’s AI-Powered Pharmacovigilance Solution
Tech Mahindra, a global leader in technology consulting and digital solutions, has partnered with NVIDIA to introduce an advanced, agentic AI-powered pharmacovigilance (PV) solution aimed at enhancing drug safety management.…
New Hope for Diabetes Patients: USV’s Xenia Empagliflozin Products
USV, a prominent Indian multinational healthcare company, has recently launched Xenia, a new line of medications containing Empagliflozin and its combinations to enhance diabetes care in India. This strategic move…
Lupin’s 10 mg Amifampridine Tablets Gain Tentative USFDA Approval for LEMS
Lupin Limited, a global pharmaceutical leader based in Mumbai, India, has received tentative approval from the United States Food and Drug Administration (USFDA) for its Amifampridine Tablets, 10 mg. This…
IPA Highlights Over-Reporting Issues in FAERS Database
The Indian Pharmaceutical Alliance (IPA) has raised concerns regarding the interpretation of data from the US Food and Drug Administration’s (FDA) Adverse Event Reporting System (FAERS) in a recent study…
Improving Sleep Quality: A Guide for Busy Entrepreneurs”
Entrepreneurs often find themselves caught between the relentless demands of their ventures and the essential need for restorative sleep. This struggle is not uncommon; a recent survey revealed that 55%…
The Future of T1D Management: Insights from IA-2A Positivity Research
Recent research has identified insulinoma-associated protein 2 autoantibody (IA-2A) positivity as a significant biomarker for predicting the progression of Type 1 Diabetes (T1D). This discovery holds potential for developing effective…
Glenmark Launches OTC Polyethylene Glycol 3350 Powder
Glenmark Therapeutics Inc., USA, a subsidiary of Glenmark Pharmaceuticals Ltd., has announced the launch of Polyethylene Glycol 3350, Powder for Solution, 17 grams per capful, available over-the-counter (OTC). This product…
New Hope for Hyperkalaemia Patients: SZC Approved by CDSCO
AstraZeneca has secured approval from the Central Drugs Standard Control Organisation (CDSCO) to import Sodium Zirconium Cyclosilicate (SZC) for the treatment of hyperkalaemia in adult patients. This development is poised…
India-Belgium Collaborations Propel Innovations in Life Sciences
The recent Belgian Economic Mission to India has underscored the growing India-Belgium Collaborations in the life sciences sector, highlighting a shared commitment to advancing healthcare innovations and addressing global health…
Women Leaders in STEM: Shaping the Future of Innovation
Women have been making significant strides in Science, Technology, Engineering, and Mathematics (STEM), breaking barriers and leading innovations across various sectors. Their contributions are not only reshaping industries but also…
Dr. Reddy’s Transfers 14 ANDAs to Senores Pharma in a Game-Changing Deal
Senores Pharmaceuticals Limited (SPL), an Ahmedabad-based pharmaceutical company, has made a significant move in the U.S. generics market by acquiring 14 Abbreviated New Drug Applications (ANDAs) from Dr. Reddy’s Laboratories…
BIRAC Invests ₹3.765 Crore in VeGen Labs For Cancer Drug Research
VeGen Labs LLP, a pioneering biotechnology startup incubated at the University of Hyderabad’s ASPIRE-TBI and ASPIRE-BioNEST, has secured ₹3.765 crore in funding from the Biotechnology Industry Research Assistance Council (BIRAC),…
Understanding the Mechanism and Efficacy of Amoxicillin-Clavulanic Acid
Amoxicillin–Clavulanic Acid, commonly known by the brand name Augmentin, is a widely used antibiotic combination effective against various bacterial infections. This combination pairs amoxicillin, a β-lactam antibiotic, with clavulanic acid,…
Cardiol’s CRD-38 : Innovations in Heart Failure Therapy
Cardiol Therapeutics has recently announced promising preclinical data on its novel therapeutic candidate, Cardiol CRD-38 (cannabidiol), indicating its potential to address unmet needs in heart failure (HF) treatment. Preclinical Findings…
Megafine Pharma Secures ₹460 Crore Investment from Motilal Oswal Alternates for Capacity Expansion
Motilal Oswal Alternate Investment Advisors (MO Alts) has committed up to ₹460 crore to acquire a majority stake in Megafine Pharma, a leading manufacturer of Active Pharmaceutical Ingredients (APIs). This…
Zydus Launches VaxiFlu-4 : India’s First Quadrivalent Flu Vaccine for 2025 Strain
Zydus Lifesciences has launched VaxiFlu-4, India’s first quadrivalent influenza vaccine tailored for the 2025 Southern Hemisphere flu season. This vaccine aligns with the World Health Organization’s (WHO) recommended composition, offering…
India’s CRDMO Sector: Projected Growth to $25 Billion by 2035
India’s Contract Research, Development, and Manufacturing Organization (CRDMO) sector is poised for significant growth, with projections indicating an expansion to $22–$25 billion by 2035. This anticipated growth underscores India’s burgeoning…
The Future of AI in Pharma: EY-Parthenon and Microsoft’s Game-Changing Framework
In a significant move poised to revolutionize the life sciences sector, EY-Parthenon and Microsoft have collaboratively introduced an Artificial Intelligence (AI) Maturity Framework for Future of AI in Pharma. This…
ASSOCHAM Nutraceutical Summit Explores the Future of Nutraceuticals in Healthcare
The 10th Nutraceutical Summit, organized by ASSOCHAM, recently convened industry leaders, policymakers, and experts to discuss the pivotal role of nutraceuticals in preventive healthcare. The summit underscored the significance of…
Biocon Biologics Expands U.S. Presence with Launch of YESINTEK Biosimilar
Biocon Biologics, a subsidiary of Biocon Ltd., has announced the U.S. launch of YESINTEK (ustekinumab-kfce), a biosimilar to Janssen’s Stelara® (ustekinumab). This significant milestone positions Biocon Biologics among the first…
Amgen India Launches $200 Million Innovation Center in Hyderabad
Amgen, a leading U.S.-based biopharmaceutical company, has inaugurated a state-of-the-art technology and innovation hub in Hyderabad, India, named Amgen India. This strategic expansion involves an initial investment of $200 million…
Key Takeaways from Jennifer Garvey Berger’s India Visit
In February 2025, Dr. Jennifer Garvey Berger, co-founder and CEO of Cultivating Leadership, visited India to lead transformative leadership sessions in New Delhi and Mumbai. These events, organized in collaboration…
Top 5 Lifestyle Habits That Harm Your Bone Health
Maintaining optimal bone health is crucial for overall well-being, as our skeletal system provides structure, protects organs, and facilitates movement. However, certain lifestyle habits can adversely affect bone density and…
The Impact of IVDR on Precision Medicine
The European Union’s In Vitro Diagnostic Regulation (IVDR) has significantly reshaped the landscape of precision medicine development within the EU. Implemented to enhance the safety and reliability of in vitro…
Bürkert and Green Elephant Biotech Join Forces for a More Sustainable Biotech Industry
In a strategic move to revolutionize cell cultivation processes within the pharmaceutical and biotechnology sectors, Bürkert Fluid Control Systems has announced a significant investment in Green Elephant Biotech, a German…
C-Suite Sumflex 2025: Global Nutraceutical Leaders to Meet in Mumbai
Nutrify Today is set to host the 4th Annual Global C-Suite Sumflex 2025 on May 8th and 9th at the Trident and Oberoi Hotels in Mumbai, India. This exclusive, invitation-only…
Sun Pharma Rises in Global Sustainability Rankings for 2025
Sun Pharmaceutical Industries Limited (Sun Pharma) has been honored by inclusion in the S&P Global Sustainability Yearbook 2025, ranking within the top 5% of pharmaceutical companies globally. This prestigious recognition…
How GenAI is Transforming Pharmaceutical Operations in India
The integration of Generative Artificial Intelligence (GenAI) into India’s pharmaceutical sector is driving significant operational transformations, as highlighted in a recent report by EY. The study reveals that 50% of…
Understanding Erectile Dysfunction: Causes, Symptoms, and Advanced Treatment Options
Erectile Dysfunction (ED) is a prevalent condition affecting men worldwide, characterized by the consistent inability to achieve or maintain an erection sufficient for satisfactory sexual performance. This condition can significantly…
Pharma Sector Correction: A Prime Opportunity for Long-Term Investors
The pharmaceutical sector has recently undergone a market correction, prompting investors to reassess the potential of pharma stocks. Elara Capital, a prominent financial services firm, views this downturn as a…
Trump’s Health Care Strategy: Implications for Drug Manufacturers
In January 2025, President Donald Trump unveiled a comprehensive Health Care Strategy poised to significantly impact the pharmaceutical industry. Trump’s Health Care Strategy, characterized by deregulation and tax incentives, aims…
How Trump’s New Tariffs Affect the Pharmaceutical Industry
President Donald Trump’s recent imposition of tariffs on pharmaceutical imports from China, Mexico, and Canada has raised concerns about potential impacts on the U.S. drug market. However, analyses suggest that…
Zydus Lifesciences Secures U.S. Rights for BEIZRAY in Partnership with Zhuhai Beihai Biotech
In a strategic move to enhance cancer treatment options in the United States, Zydus Lifesciences has entered into an exclusive licensing, supply, and commercialization agreement with Zhuhai Beihai Biotech Co.…